With many countries continuing to report a growing number of H1N1 (swine flu) cases, Keiji Fukuda, special adviser to the WHO director general on pandemic influenza said Thursday it was too early to declare the pandemic over, the Washington Post reports.
Pneumonia & Flu
Scientific American Examines Neglected Tropical Diseases A Scientific American article examines recent efforts to tackle neglected tropical diseases (NTDs). The author writes “NTDs have plagued humankind for thousands of years. â€¦ What is new, however, is that donors, drugmakers, health ministries in low- and middle-income countries, the World Health Organization…
The antibodies produced by individuals who fought off H1N1 (swine flu) infection last year may bring researchers one step closer to their quest to develop a “universal” flu vaccine, U.S. researchers said Monday, HealthDay News/Bloomberg Businessweek reports. As the researchers from Emory University and the University of Chicago report in the Jan. 10 issue of the Journal of Experimental Medicine, “people who were infected with the H1N1 virus and recovered had a special immune response, producing antibodies that protect against a wide variety of flu strains,” the news service writes (1/10).
Also In Global Health News: Global Risks Report; Japan’s Donation To WFP; Global Fund Freeze On Ivory Coast; Pneumonia Vaccine In Kenya
World Economic Forum Global Risks Report Highlights Concerns Over Demand For Food, Water “Nations are in no position to deal with any more big shocks, the World Economic Forum said on Wednesday, yet risks are rising with the threat of ‘disastrous impacts,'” the organization noted in its Global Risks 2011…
“Scientists have developed genetically modified [GM] chickens that don’t transmit bird flu [H5N1] to other chickens,” HealthDay News/Bloomberg Businessweek reports. “This achievement could stop bird flu outbreaks from spreading within poultry flocks and possibly reduce the risk of bird flu epidemics that could lead to flu virus epidemics in humans, according to the researchers at the Universities of Cambridge and Edinburgh in the United Kingdom,” whose findings appear in the Jan. 14 issue of the journal Science, according to the news service (Preidt, 1/13).
BMJ News reports on the ongoing external investigation of the WHO’s handling of the 2009 H1N1 (swine flu) pandemic, following recent statements to the WHO’s executive board meeting by review committee chairman, Harvey Fineberg. Despite initial expectations that the external review committee would produce a draft of its findings in January, Fineberg “said the panel was planning a meeting on 28-30 March, and it would distribute in advance to all WHO member nations copies of a draft summary of its principal findings, conclusions, and recommendations, for comments and reactions, before it finalises the report.”
Al Jazeera examines the toll pneumonia and diarrhea take on children living in developing countries and how the GAVI Alliance is working to help improve health outcomes among children through the distribution of pneumonia vaccines around the world.
Innovative Health Financing Can Benefit Global Health, Pharma: “The launch of pneumococcal vaccination in Nicaragua under AMC [advance market commitment] has shown that innovative approaches to health financing can benefit both global health and pharmaceutical companies,” according toÂ a Lancet Infectious Diseases editorial that describes how the roll-out of GAVI initiative…
Also In Global Health News: Medical Tourism In Southeast Asia; Cholera, Yellow Fever In Ivory Coast; U.S. Aid To Egypt; Universal Coverage In Mexico; Pneumonia’s Evolution
IRIN Examines Medical Tourism’s Affect In Southeast Asia IRIN examines how “rapid growth in medical tourism” in southeast Asian countries is affecting health systems in the region. According to the WHO, “medical tourism is leading to some highly skilled specialists, as well as other trained medical staff, leaving public health…
Stockpiling Flu Drugs, Vaccines Reduces Impact Of Pandemic, But Option Out Of Reach For Most Countries, Study Finds
“Stockpiling antiviral flu drugs and vaccines saves lives and reduces disease in a flu pandemic,” but the cost to maintain such a stockpile and deploy interventions in the event of an outbreak “is too expensive for around two thirds of the world’s population, scientists said on Wednesday,” Reuters reports.